The preoperative testing at laboratories in Najaf are being performed on patients at the time of the surgery in order to do this evaluation of blood-borne viruses
Downloads
Al-Sadir Teaching Hospital, Najaf, Iraq was the surrounding for this study that was done during the window of time from the 1st of January to the 1st of November of the same year. A descriptive, cross-sectional, hospital-based study of hospitals is investigated. The research was conducted during January, 1st 2023 and November 1, 2023 in the course of studies. The project evlaution was launched on 21st of January and finalized on 1st of November. The purpose of this researched was to determine proportion of patients who were infected with the blood borne diseases such as human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV). All of these viruses are transmitted because the blood carries them. The technique was considered necessary to establish the amount of viral infection in these patients. ELISA testing was among the components, of the pre- surgical virus therapy, which was received by the patient and it was performed on the blood samples collected from the patient.Eventually we came to the conclusion that the procedures were applied as implied in the system. In our investigations, we determined that the Human Papilloma Virus (HPV) is the one virus that had been identified to be infecting the people whose cases were detected by the examination process. The second most well-known virus after Human Virus (HCV) that is also categorized as one of the human viruses is the Human and Human Immune Globaly Viruses complex (HIV). I state emphatically discrimination or age bias was non existent during data collection at any point in time of the whole process. I got the data together in a process which of a ten months' duration and took place solely in this particular educational organization. A total of 125 individuals were tested positive out of which 64 were affected by HBV, 60 (60%) got affected by HCV, and 7 (70%) were affected by HIV. The isolation of the virus was only possible when it was passed on by all male who were tested. The girls had a unique and admirable quality: not a single one of them tested positive for the infection. It was evident among the people affected that about two thirds were male. Actually, only less than 1/3 (30%) of the females getting tested HIV positive, whereas 5 (43.4%) of them had HBV and even 5 (45%) of them showed the HCV result Thus, it is evident with the result seen that the number of cases of women from prevention to men who visited the health center was much lower. We look forward to having 19,925 folks at the donation drive having filled up the collection tubes with their blood. Via the study of a total of 1,330 Hepatitis B virus cases, the test was found positive in (145) of them, and negative only in the (1205) remaining cases. By which implies gives us 19925 which is definitely it is the quantity of blood to be collected
Alashary, H. (2013). Prevalence and risk factors for viral hepatitis B and hepatitis C among blood donors attending Al Leith General Hospital, Saudi Arabia. Journal of Research in Humanities and Social Science, 7(11), 42-46.
Al-Rubaye, A., Tariq, Z., & Alrubaiy, L. (2016). Prevalence of hepatitis B seromarkers and hepatitis C antibodies in blood donors in Basra, Iraq. BMJ Open Gastroenterology, 3(1).
Alter, M. J. (2006). Epidemiology of viral hepatitis and coinfections. Journal of Hepatology, 44, S6-S9.
Blut, A. K. (2006). Procedure of Look Back (pursuant to §19 Transfusion Law). Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 49, 940-957.
Bourinbaiar, A. S., Nagorny, R., & Tan, X. (2017). Heaviness of HIV particles in quantum relation to viral infectiousness and responsiveness to interferon. In J. M. Andrieu (Ed.), Viral Quantitation in HIV Infection (pp. 41-52). John Libbey Eurotext.
Bevilacqua, E. (2009). Genetic factors in mother-to-child transmission of HCV infection. Virology, 390(1), 64-70.
Brendon. (1998). HIV and hepatotropic viruses: Interaction and treatment. Indian Journal of Medical Microbiology, 16, 4-11.
Bibi, S., Dars, S., Ashfaq, S., Qazi, R. A., & Akhund, S. (2013). Seroprevalence and risk factors for hepatitis C virus (HCV) infection in pregnant women attending public sector tertiary care hospital in Hyderabad Sindh. Pakistan Journal of Medical Sciences, 29(2), 505-508.
Chung, R. T. (2006). Hepatitis C and B viruses: The new opportunities in HIV infection. Top HIV Med, 14, 78-83.
Chuang, S. C., Vecchia, C. L., & Boffetta, P. (2009). Liver cancer: Descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Letters, 286(1), 9-14.
Donato, F. (2002). Alcohol and Hepatocellular Carcinoma: The Effect of Lifetime Intake and Hepatitis B Virus Infections in Men and Women. American Journal of Epidemiology, 155(4), 323-331.
Farooq, A., Waheed, U., Zaheer, H. A., Aldakheel, F., Alduraywish, S., & Arshad, M. (2017). Detection of HBsAg mutants in the blood donor population of Pakistan. PLoS One, 12(11), e0188066.
Ganem, D., & Prince, A. M. (2004). Hepatitis B infection: Natural history and clinical consequences. New England Journal of Medicine, 350, 1118-1129.
Gangadharan, B., Antrobus, R., Dwek, R. A., & Zitzmann, N. (2007). Novel serum biomarker candidates for liver fibrosis in hepatitis C patients. Clinical Chemistry, 53(10), 1792-1799.
Grebely, J., & Dore, G. J. (2011). Prevention of hepatitis C virus in injecting drug users: A narrow window of opportunity. Journal of Infectious Diseases, 203(5), 571-574.
Gürtler, L., Mühlbacher, A., Michl, U., Hofmann, H., Paggi, G. G., Bossi, V., Thorstensson, R., G-Villaescusa, R., Eiras, A., Hernandez, J. M., Melchior, W., Donie, F., & Weber, B. (1998). Reduction of the diagnostic window with a new combined p24 antigen and human immunodeficiency virus antibody screening assay. Journal of Virological Methods, 75, 27-38.
Guadagnino, V. (n.d.). Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: A community-based survey in southern Italy. Hepatology, 26(4), 1006-1011.
Hassan, M. M. (2002). Risk factors for hepatocellular carcinoma: Synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology, 36(5), 1206-1213.
Hollinger, F. B., & Liang, T. J. (2001). Hepatitis B virus. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, & Editors, Fields Virology (4th ed., pp. 2971-3036). Lippincott-Raven Publishers.
Hoofnagle, J. H., & di Bisceglie, A. M. (1997). The treatment of chronic viral hepatitis. New England Journal of Medicine, 336, 347-356.
Imran, M., Hassan, M., Dur-E-Ahmad, M., & Khan, A. (2013). A comparison of a deterministic and stochastic model for hepatitis C with an isolation stage. Journal of Biological Dynamics, 7(1), 276-301.
Janssen, R. S., Satten, G. A., Stramer, S. L., Rawal, B. D., O'Brien, T. R., Weiblen, B. J., Hecht, F. M., Jack, N., Cleghorn, F. R., Kahn, J. O., Chesney, M. A., & Busch, M. P. (2016). New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA, 280, 42-48.
Kamar, N. (2014). Hepatitis E virus infection. Clinical Microbiology Reviews, 27, 116-138.
Lagarde, E., Dirk, T., Puren, A., Reathe, R., & Bertran, A. (2003). Acceptability of male circumcision as a tool for preventing HIV infection in a highly infected community in South Africa. AIDS, 17(1), 89-95.
Liaw, Y. F. (2009). Natural history of chronic hepatitis B infection and long-term outcome under treatment. Liver International, 29, S1, 100-107.
Luciw, P. A. (1996). Human immunodeficiency viruses and their replication. In B. N. Fields (Ed.), Virology (3rd ed.). Lippincott-Raven.
Lynn Riddell, A., & Kelly Morris. (2002). Blood borne virus infection: The occupational risks. Surgery (Oxford), 20(9), 208-211.
Mathers, B. M., Degenhardt, L., Ali, H., Wiessing, L., Hickman, M., Mattick, R. P., & Strathdee, S. A. (2010). HIV prevention, treatment, and care services for people who inject drugs: A systematic review of global, regional, and national coverage. Lancet, 375(9719), 1014-1028.
McCormack, S., Dunn, D. T., Desai, M., Dolling, D. I., Gafos, M., Gilson, R., & Schembri, G. (2016). Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): Effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet, 387(10013), 53-60.
Menne, S., & Tennant, B. C. (1999). Unraveling hepatitis B virus infection of mice and men (and woodchucks and ducks). Nature Medicine, 5, 1125-1126.
Merican, I. (2000). Chronic hepatitis B virus infection in Asian countries. Journal of Gastroenterology and Hepatology, 15(12), 1356-1361.
Perz, J. F., Armstrong, G. L., Farrington, L. A., Hutin, Y. J. F., & Bell, B. P. (2006). The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. Journal of Hepatology, 45, 529-538.
Polsky, B. (2000). Human immunodeficiency virus and hepatitis B and C coinfection; pathogenic interactions, natural history, and therapy. AIDS Clinical Review, 263-306.
Ploss, A., & Dubuisson, J. (2012). New advances in the molecular biology of hepatitis C virus infection: Towards the identification of new treatment targets. Gut, 61 Suppl 1, i25-35.
Purcell, R. (1997). The hepatitis C virus: Overview. Hepatology, 26 Suppl 3, 11S-14S.
Rabenau, H., Bannert, N., Berger, A., Donoso Mantke, O., Eberle, J., Enders, M., Grunert, H. P., Gürtler, L., Heim, A., Huzly, D., Kaiser, R., Kron, K., Nick, S., Kücherer, C., Nübling, M., Obermeier, M., Panning, M., & Zeichhardt, H. (2015). Detection of an infection with human immunodeficiency virus (HIV): Serological screening followed by confirmatory diagnostics through antibody-based test systems and/or HIV nucleic acid detection. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 8, 877-886.
Raza, S. A., Clifford, G. M., & Franceschi, S. (2007). Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: A systematic review. British Journal of Cancer, 96(7), 1127-1134.
Romona D. Govender, & Muhammad Jawad Hashim. (2021). Global Epidemiology of HIV/AIDS: A Resurgence in North America and Europe. 11(3), 296–301.
Seeger, C., & Mason, W. S. (2000). Hepatitis B virus biology. Microbiology & Molecular Biology Reviews, 64, 51–68.
Si, L., Whiteside, T. L., & Van Thiel, D. H. (1984). Lymphocyte subpopulations at the site of "piecemeal" necrosis in end-stage chronic liver diseases and rejecting liver allografts in cyclosporine-treated patients. Lab Invest, 50, 341.
Saeed, U., & Manzoor, S. (2014). Risk Factors Associated with Transmission of Hepatitis B and Hepatitis C Virus in Pakistan. Global Journal of Medicine.
Thualfakar, H., & Hassan, A. (2020). Prevalence of hepatitis B virus and C in Najaf governorate, Iraq. International Journal of Pharmaceutical Research, 12(3).
Vallari, A., Holzmayer, V., Harris, B., Yamaguchi, J., Ngansop, C., Makamche, F., Mbanya, D., Kaptué, L., Ndembi, N., Gürtler, L., Devare, S., & Brennan, C. A. (2011). Confirmation of putative HIV-1 group P in Cameroon. Journal of Virology, 85, 1403-1407.
Vital, S. De. (2008). Hepatitis C virus, non-Hodgkin's lymphomas, and hepatocellular carcinoma. Cancer, 77, 2032-2035.
Waheed, Y., Shafi, T., Safi, S. Z., & Qadri, I. (2009). Hepatitis C virus in Pakistan: A systematic review of prevalence, genotypes, and risk factors. World Journal of Gastroenterology, 15(45), 5647-5653.
Xuebin Tian, Jingjing Chen, Xi Wang, Yiwen Xie, Xiaodi Zhang, Dating Han, Haijing Fu, Wanpeng Yin, & Nanping Wu (corresponding author). (2019). Global, regional, and national HIV/AIDS disease burden levels and trends in 1990–2019: A systematic analysis for the global burden of disease.
Copyright (c) 2024 Alaa Mahdy obaid Khzal

This work is licensed under a Creative Commons Attribution 4.0 International License.














